Mercury Pharmaceuticals UK

Oct 2026

Nearly one in three women with autoimmune diseases waited at least four years for a diagnosis, survey finds

An international study of 6,607 adults with autoimmune diseases found that female participants reported longer diagnostic delays, more clinician visits, and higher rates of perceived psychiatric and psychosomatic misdiagnoses than males. The findings suggest sex-related differences in diagnostic experiences, although the researchers cautioned that patient-reported misdiagnoses were not independently verified and the causes of these disparities remain uncertain.

Oct 2026

Scientists restore memory-linked neuron function in Alzheimer's mice

Researchers were able to restore the function of neurons linked to cognitive function and information processing in mice that mimic key features of Alzheimer's disease, showing early promise for the development of a similar targeted therapy in humans.

Oct 2026

Mount Sinai wins NIH grant to test community-based hypertension care model in rural Ghana

Researchers at the Icahn School of Medicine at Mount Sinai have received a $3.3 million, five-year grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to test an innovative community-based primary care model for high blood pressure in rural Ghana.

Oct 2026

Radiology departments face gaps in family medical leave policies

A recent study in the Journal of the American College of Radiology (JACR®) suggests that paid family and medical leave (PFML) policies offered by U.S. academic and radiation oncology programs, while widely available, are implemented inconsistently across programs.

Oct 2026

New paper urges adoption of green AI in healthcare

AI is already widely used in hospitals and medical research. Can a new way of thinking unleash the technology’s green credentials?

Oct 2026

CHEST announces first pulmonary certification program for nurse practitioners and physician assistants

Following a comprehensive discovery initiative examining the needs of advanced practice providers (APPs) in pulmonary medicine, the American College of Chest Physicians (CHEST) announces plans to move forward with the development of a pulmonary-focused education and certification program for nurse practitioners (NPs) and physician assistants/associates (PAs).